• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. RAP FEMORAL VENOUS CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. RAP FEMORAL VENOUS CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number 200-150
Device Problem Split (2537)
Patient Problem Death (1802)
Event Date 03/08/2018
Event Type  Death  
Manufacturer Narrative
Patient identifier was not provided.Patient weight was not provided.The device lot number is unknown, as the packaging was discarded.This information will be provided in a supplemental report if made available.As the serial number is unknown, the device manufacture date could not be determined.This information will be provided in a supplemental report if made available.During follow-up communication with the supplier of the device, livanova usa was informed that this type of issue has been seen in the past.The supplier indicated that in previous cases, the failure was attributed to "the use of a suture tightly applied around the point of failure of the cannula." additional follow-up communication with a clinical expert also presented this scenario as a likely cause.However, an investigation has not yet been performed, and it is unknown at this time how the cannula became split or if the device malfunction was in any way related to the patient death.Multiple attempts have been made to gather additional information from the customer regarding the duration of the ecmo procedure, the nature of the setup and device malfunction, and the cause of death of the patient.At this time, no additional information has been provided by the facility.If any additional information pertinent to the reported event is received, it will be provided in a supplemental report.Device not yet returned.
 
Event Description
Livanova received a report that the user experienced flow issues with the femoral venous cannula during an ecmo procedure on a female patient.Inspection of the cannula identified that it had split at the suture line.The report indicated that the patient was sick and was not doing well before the procedure had been initiated.The patient reportedly already had coded in the er twice.The patient expired on (b)(6) 2018.
 
Manufacturer Narrative
The involved cannula was returned to livanova for evaluation.Visual inspection confirmed that the cannula was split roughly 0.5" from the "50" mark on the device.The split was located distal to the mark and was such that there were two separate openings on the cannula, with a piece of tubing stuck in the middle that was secured by the section of tubing that was still intact.The edges of the split were slightly rough and not perfectly straight.The spring of the cannula was completely intact.The cannula has been forwarded to the supplier for additional evaluation.In addition, several unused cannula were also returned to livanova.The supplier has been notified and will conduct additional investigation related to the individual returned devices and their lot numbers.If any additional information pertinent to the reported event is received, it will be provided in a supplemental report.
 
Manufacturer Narrative
Livanova has received the response from the supplier regarding the investigation into this issue.The supplier reviewed the dhr, the expiration date and shelf life for the products used to manufacture this lot of cannula and no issues were found.No manufacturing process failures could be identified.During follow-up communication with the customer, livanova learned that the facility reportedly attempted to duplicate the failure and found that it could be reproduced if the sutures were secured around the cannula too tightly.Further clarification was requested about the length of the ecmo procedure.However, the customer declined to provide any further information.The actual cause of the patient demise was not reported.Reportedly the patient was very sick before the procedure.Based on the medical expertise preformed by livanova, it is possible the cannula split was caused by the user technique however the cause of the patient death remains unknown.This is the first time this kind of event is reported to livanova.Though an exact root cause of the cannula split could not be confirmed, a contributing factor to the event is potentially a too tight sutures around the cannula.For this reason livanova preventatively decided to initiate a capa to evaluate possible improvement.If any additional information pertinent to the reported event is received, it will be provided in a supplemental report.
 
Event Description
See initial report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAP FEMORAL VENOUS CANNULA
Type of Device
CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
LIVANOVA USA, INC.
14401 w 65th way
arvada CO 80004
Manufacturer (Section G)
LIVANOVA USA, INC.
14401 w 65th way
arvada CO 80004
Manufacturer Contact
joan ceasar
14401 w. 65th way
arvada, CO 80004
2812287260
MDR Report Key7399657
MDR Text Key104459668
Report Number1718850-2018-00007
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K070749
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 07/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2018
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Catalogue Number200-150
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received06/14/2018
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age40 YR
-
-